<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cell Syst</journal-id><journal-id journal-id-type="iso-abbrev">Cell Syst</journal-id><journal-title-group><journal-title>Cell Systems</journal-title></journal-title-group><issn pub-type="ppub">2405-4712</issn><issn pub-type="epub">2405-4720</issn><publisher><publisher-name>Cell Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27136687</article-id><article-id pub-id-type="pmc">4802413</article-id><article-id pub-id-type="publisher-id">S2405-4712(16)00002-8</article-id><article-id pub-id-type="doi">10.1016/j.cels.2016.01.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Dynamical Framework for the All-or-None G1/S Transition</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Barr</surname><given-names>Alexis&#x000a0;R.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Heldt</surname><given-names>Frank&#x000a0;S.</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Tongli</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Bakal</surname><given-names>Chris</given-names></name><email>chris.bakal@icr.ac.uk</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author"><name><surname>Nov&#x000e1;k</surname><given-names>B&#x000e9;la</given-names></name><email>bela.novak@bioch.ox.ac.uk</email><xref rid="aff2" ref-type="aff">2</xref><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK</aff><aff id="aff2"><label>2</label>Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>chris.bakal@icr.ac.uk</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author <email>bela.novak@bioch.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>27</day><month>1</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><day>27</day><month>1</month><year>2016</year></pub-date><volume>2</volume><issue>1</issue><fpage>27</fpage><lpage>37</lpage><history><date date-type="received"><day>29</day><month>6</month><year>2015</year></date><date date-type="rev-recd"><day>9</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>4</day><month>1</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 The Authors</copyright-statement><copyright-year>2016</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract><title>Summary</title><p>The transition from G1 into DNA replication (S phase) is an emergent behavior resulting from dynamic and complex interactions between cyclin-dependent kinases (Cdks), Cdk inhibitors (CKIs), and the anaphase-promoting complex/cyclosome (APC/C). Understanding the cellular decision to commit to S&#x000a0;phase requires a quantitative description of these interactions. We apply quantitative imaging of single human cells to track the expression of G1/S regulators and use these data to parametrize a stochastic mathematical model of the G1/S transition. We show that a rapid, proteolytic, double-negative feedback loop between Cdk2:Cyclin and the Cdk inhibitor p27<sup>Kip1</sup> drives a switch-like entry into S phase. Furthermore, our model predicts that increasing Emi1 levels throughout S phase are critical in maintaining irreversibility of the G1/S transition, which we validate using Emi1 knockdown and live imaging of G1/S reporters. This work provides insight into the general design principles of the signaling networks governing the temporally abrupt transitions between cell-cycle phases.</p></abstract><abstract abstract-type="graphical"><title>Graphical Abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights"><title>Highlights</title><p><list list-type="simple"><list-item id="u0010"><label>&#x02022;</label><p>A model of the human G1/S transition is derived from single-cell imaging of key regulators</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>Double-negative feedback between Cdk2:CycE and p27 drives a switch-like transition</p></list-item><list-item id="u0020"><label>&#x02022;</label><p>The APC/C inhibitor Emi1 ensures that the G1/S transition is kept irreversible</p></list-item><list-item id="u0025"><label>&#x02022;</label><p>Modeling provides insight into the differences in Cdk2 activity between cancer and normal cells</p></list-item></list></p></abstract><abstract abstract-type="teaser"><p>The principles underlying switch-like and irreversible transitions between cell-cycle phases are poorly understood in mammalian cells. Barr et&#x000a0;al. have used quantitative real-time imaging of regulators of the G1-to-S transition in single human cells to develop a mechanistic model to show how this network drives rapid and irreversible commitment to cell-cycle progression.</p></abstract></article-meta><notes><p id="misc0010">Published: January 27, 2016</p></notes></front><body><sec id="sec1"><title>Introduction</title><p>Through decades of painstaking genetic and biochemical research, the components regulating cell-cycle progression have been identified, but how these components dynamically interact to drive this progression in either normal or cancerous human cells is poorly understood. In mammalian cells, the decision to enter the cell cycle is made at the restriction point, which is analogous to the Start transition in yeast (<xref rid="bib27" ref-type="bibr">Johnson and Skotheim, 2013</xref>, <xref rid="bib73" ref-type="bibr">Zetterberg et&#x000a0;al., 1995</xref>). Restriction point/Start is followed by a separate G1/S transition where the cell becomes committed to DNA replication. In yeast, Start is characterized by a transcriptional burst that leads to the accumulation of G1- and S-phase cyclins (Clns and Clbs, respectively). This transcriptional activation is driven by a positive feedback loop (<xref rid="bib59" ref-type="bibr">Skotheim et&#x000a0;al., 2008</xref>) that makes Start an irreversible transition (<xref rid="bib7" ref-type="bibr">Charvin et&#x000a0;al., 2010</xref>). The accumulation of S-phase cyclins is necessary, but not sufficient, to initiate DNA replication because the activity of Cdk1:Clb complexes is initially masked by their stoichiometric inhibitor, the Cyclin-dependent Kinase Inhibitor (CKI) Sic1 (<xref rid="bib56" ref-type="bibr">Schwob et&#x000a0;al., 1994</xref>); note that the colon indicates that Cdk1 and Clb are in a protein complex. The G1/S transition is triggered by the proteolytic degradation of Sic1. Sic1 degradation is initiated by Cln:Cdk1 activity (<xref rid="bib44" ref-type="bibr">Nash et&#x000a0;al., 2001</xref>) and continues to be rapidly degraded by the Clb:Cdk1 kinases as they become activated (<xref rid="bib32" ref-type="bibr">K&#x000f5;ivom&#x000e4;gi et&#x000a0;al., 2011</xref>, <xref rid="bib69" ref-type="bibr">Yang et&#x000a0;al., 2013</xref>).</p><p>A transcriptional positive-feedback loop similar to the Start network in yeasts operates at the restriction point in mammalian cells (<xref rid="bib3" ref-type="bibr">Bertoli et&#x000a0;al., 2013</xref>, <xref rid="bib12" ref-type="bibr">Cross et&#x000a0;al., 2011</xref>). CyclinE:Cdk2 promotes <italic>CyclinE</italic> transcription through activation of its transcription factor (E2F) (<xref rid="bib20" ref-type="bibr">Geng et&#x000a0;al., 1996</xref>, <xref rid="bib46" ref-type="bibr">Ohtani et&#x000a0;al., 1995</xref>, <xref rid="bib67" ref-type="bibr">Weinberg, 1995</xref>). A bistable switch generated by transcriptional feedback makes the transition through the restriction point irreversible (<xref rid="bib70" ref-type="bibr">Yao et&#x000a0;al., 2008</xref>). Following the transition past the restriction point, E2F-mediated transcription leads to the accumulation of both CyclinE and CyclinA, which form complexes with Cdk2, resulting in its activation, which serves as the trigger for S-phase entry. Similar to yeast, activation of Cdk2:S-phase Cyclin complexes requires the proteolytic degradation of their stoichiometric CKIs, p27<sup>Kip1</sup>, and p21<sup>Cip1</sup> (<xref rid="bib58" ref-type="bibr">Sherr and Roberts, 1999</xref>).</p><p>The proteolytic double-negative feedback between CKI and S-phase kinases in yeast leads to G1 and S being two discrete, alternative states. Furthermore, this double-negative feedback loop ensures that commitment to S phase in yeast is irreversible (<xref rid="bib8" ref-type="bibr">Chen et&#x000a0;al., 2000</xref>, <xref rid="bib11" ref-type="bibr">Cross et&#x000a0;al., 2002</xref>, <xref rid="bib64" ref-type="bibr">Verdugo et&#x000a0;al., 2013</xref>, <xref rid="bib69" ref-type="bibr">Yang et&#x000a0;al., 2013</xref>). While the core regulatory machinery (i.e., the proteolytic double-negative feedback loop) of the G1/S transition is conserved between yeast and man, this machinery has been extensively elaborated upon. This elaboration is in the form of many more regulatory components (Cyclins, CDKs, CKIs), with sometimes partially overlapping functions, and additional interactions between conserved components (<xref rid="bib12" ref-type="bibr">Cross et&#x000a0;al., 2011</xref>). Thus, an unresolved question is whether the mammalian G1/S transition exhibits similar system-level properties as yeast. Answering this question is important not only to gain insight into the mammalian G1/S transition, but also to understand how particular behaviors observed in yeast, such as the irreversible switching between discrete states, can be retained when the size and complexity of the regulatory networks governing these behaviors increase during evolution.</p><p>Describing the systems-level interactions between Cdk2, CyclinE, CyclinA, and CKI is also highly relevant to gaining insight into the dysregulated G1/S progression of cancer cells, where mutations and epigenetic events often conspire to increase CyclinE and downregulate p27<sup>Kip1</sup> levels (<xref rid="bib9" ref-type="bibr">Chu et&#x000a0;al., 2008</xref>, <xref rid="bib18" ref-type="bibr">Fero et&#x000a0;al., 1996</xref>, <xref rid="bib24" ref-type="bibr">Hershko, 2010</xref>, <xref rid="bib29" ref-type="bibr">Kiyokawa et&#x000a0;al., 1996</xref>, <xref rid="bib43" ref-type="bibr">Nakayama et&#x000a0;al., 1996</xref>, <xref rid="bib53" ref-type="bibr">Scaltriti et&#x000a0;al., 2011</xref>). Moreover, many cancer cells do not have an intact restriction point (<xref rid="bib1" ref-type="bibr">Asghar et&#x000a0;al., 2015</xref>), and thus, inhibition of the G1/S transition is an attractive therapeutic target to stop these cancer cells from proliferating. To inhibit S-phase entry effectively, we need a quantitative understanding of how Cdk2 activity is a function of Cyclins, CKIs, and APC/C components and how this drives cell-cycle progression.</p><p>Only a handful of studies have been able to describe the systems-level logic of progression through different cell-cycle phases in mammalian cells (<xref rid="bib50" ref-type="bibr">Pomerening et&#x000a0;al., 2008</xref>, <xref rid="bib70" ref-type="bibr">Yao et&#x000a0;al., 2008</xref>, <xref rid="bib71" ref-type="bibr">Yuan et&#x000a0;al., 2014</xref>), likely because it has been difficult to quantify the levels and/or activity of different network components at a single cell level. Single cell, time-lapse data are essential to generate predictive quantitative models because such models require information not only on the signaling state of a cell at a given time, but also regarding the cell&#x02019;s history, which is unattainable using population-based measurements.</p><p>Here we describe an experimental system to quantify the real-time protein expression of key regulatory molecules involved in the G1/S transition (CyclinA2, CyclinE1, and p27<sup>Kip1</sup>) and Cdk2 activity. We correlate these changes with cellular fate (initiation of DNA replication) in single proliferating cells. We chose to use HeLa cells as they are an excellent model for studying dysregulated G1/S progression as like almost all cancer cells, they have lost the function of pRb (an inhibitor of E2F), do not have an intact restriction point, and enter G1/S directly after cell division (<xref rid="bib40" ref-type="bibr">Moody and Laimins, 2010</xref>, <xref rid="bib55" ref-type="bibr">Schwarz et&#x000a0;al., 1985</xref>). We used single cell imaging data of protein levels throughout the G1/S transition to construct a mathematical model of this transition. This work reveals that a switch-like G1/S transition is driven by the mutual antagonism between Cdk2 and p27<sup>Kip1</sup>. Furthermore, our model provides a mechanistic explanation for how Emi1 keeps the G1/S transition irreversible to prevent DNA re-replication.</p></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Establishing a System to Analyze the Dynamics of the G1/S Transition in Human Cancer Cells</title><p>We first sought to follow the dynamics of Cyclin and p27<sup>Kip1</sup> expression in HeLa cells at the G1/S transition. We genetically modified bacterial artificial chromosomes (BACs; <xref rid="bib10" ref-type="bibr">Ciotta et&#x000a0;al., 2011</xref>, <xref rid="bib26" ref-type="bibr">Hutchins et&#x000a0;al., 2010</xref>) to generate GFP-tagged p27<sup>Kip1</sup>, CyclinE1, and CyclinA2, under the control of their endogenous promoters. These constructs were used to generate clonal cell lines for this study (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>A). Expression of all three reporters mimicked the localization and expression of their endogenous counterparts (<xref rid="fig1" ref-type="fig">Figures 1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>B&#x02013;S1D), indicating that the GFP&#x000a0;tag did not affect their cell-cycle-mediated regulation. Moreover, the GFP tag did not prevent S-phase entry or cell-cycle progression (<xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>E and S1F) and did not affect protein degradation rates (<xref rid="mmc1" ref-type="supplementary-material">Figures S1</xref>G and S1H; timely degradation of CyclinA2-GFP has been validated in <xref rid="bib13" ref-type="bibr">den Elzen and Pines, 2001</xref>). Thus, our system accurately reflects Cyclin and p27<sup>Kip1</sup> expression throughout the G1/S transition.</p><p>To correlate Cyclin and CKI expression with the G1/S transition, we co-imaged each GFP tagged protein with LSS2-mKate-PCNA (<xref rid="fig1" ref-type="fig">Figures 1</xref>, <xref rid="mmc1" ref-type="supplementary-material">S1</xref>C, and S1D; <xref rid="mmc2" ref-type="supplementary-material">Movies S1</xref>, <xref rid="mmc3" ref-type="supplementary-material">S2</xref>, and <xref rid="mmc4" ref-type="supplementary-material">S3</xref>). Fluorescently labeled PCNA is a robust and well-used marker of DNA replication in mammalian cells (<xref rid="bib17" ref-type="bibr">Essers et&#x000a0;al., 2005</xref>, <xref rid="bib23" ref-type="bibr">Held et&#x000a0;al., 2010</xref>, <xref rid="bib34" ref-type="bibr">Leonhardt et&#x000a0;al., 2000</xref>, <xref rid="bib50" ref-type="bibr">Pomerening et&#x000a0;al., 2008</xref>) and does not interfere with cell-cycle progression in our system. When cells enter S phase, PCNA fluorescence rapidly increases and then switches to a punctate localization (<xref rid="fig1" ref-type="fig">Figures 1</xref>A&#x02013;1D, <xref rid="mmc1" ref-type="supplementary-material">S1</xref>C, and S1D). Since the duration of G1 varies between cells, LSS2-mKate-PCNA localization can act as a marker to pseudo-synchronize cells at the G1/S transition, which we define as time zero (<xref rid="fig1" ref-type="fig">Figures 1</xref>A&#x02013;1C).</p><p>We next sought to define the temporal regulation of each of the GFP tagged G1/S regulators throughout the G1/S transition. Consistent with previous observations made in HeLa cell populations by western blotting (<xref rid="bib6" ref-type="bibr">Carrano et&#x000a0;al., 1999</xref>), we found that p27<sup>Kip1</sup>-GFP is absent after cell division, accumulates rapidly, and is then degraded, starting approximately 5&#x02013;10&#x000a0;hr after mitotic exit (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>D). Through live single cell imaging, we observed a decelerating pattern of p27<sup>Kip1</sup>-GFP accumulation during G1 that strongly suggests that p27<sup>Kip1</sup> degradation is turned off after cell division. By imaging p27<sup>Kip1</sup>-GFP and LSS2-mKate PCNA in the same cell, we saw that p27<sup>Kip1</sup>-GFP was very rapidly degraded immediately prior to S-phase entry (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>D). Western blotting of synchronized cell lysates did not show this rapid degradation because in a cell population cells enter S phase at different rates (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>G), and thus, p27<sup>Kip1</sup> degradation appears slow.</p><p>We observed that CyclinE1-GFP accumulates prior to the G1/S transition and is only degraded after S-phase entry (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>B), consistent with previous reports of CyclinE levels in HeLa cell populations determined by western blotting of lysates from synchronized cells (<xref rid="bib15" ref-type="bibr">Duli&#x00107; et&#x000a0;al., 1992</xref>, <xref rid="bib30" ref-type="bibr">Koff et&#x000a0;al., 1992</xref>). Single cell imaging also revealed that CyclinE1-GFP levels reach a short plateau immediately after S-phase entry, consistent with the plateau reached by endogenous CyclinE as detected by western blotting (<xref rid="bib71" ref-type="bibr">Yuan et&#x000a0;al., 2014</xref>). Moreover, accumulation of CyclinE1-GFP occurred in an accelerated fashion.</p><p>In contrast to CyclinE1-GFP, CyclinA2-GFP remained low during G1, despite the fact that their common transcription factor (E2F) was active during G1 (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C). Imaging of CyclinA2-GFP showed that CyclinA2 protein only began to accumulate in a linear manner after the G1/S transition (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C), consistent with previous reports from western blotting of HeLa cell lysates (<xref rid="bib49" ref-type="bibr">Pines and Hunter, 1990</xref>). This suggests that CyclinA2 is degraded during G1.</p><p>Notably, the levels of CyclinE and CyclinA alone do not reveal Cdk2 activity since Cyclin binding alone is not necessarily sufficient to activate Cdks (reviewed in <xref rid="bib41" ref-type="bibr">Morgan, 1997</xref>). To measure Cdk2 activity, we generated a Cdk2 activity sensor (CDK2L-GFP), a slightly longer version of the recently published DHB-Ven Cdk2 sensor (see <xref rid="sec4" ref-type="sec">Experimental Procedures</xref>; <xref rid="bib22" ref-type="bibr">Gu et&#x000a0;al., 2004</xref>, <xref rid="bib61" ref-type="bibr">Spencer et&#x000a0;al., 2013</xref>). Briefly, this is a fluorescent sensor of&#x000a0;Cdk2 activity based on the C-terminal fragment of DNA Helicase B. When phosphorylated by Cdk2, the sensor leaves the&#x000a0;nucleus. By measuring the cytoplasmic:nuclear ratio of CDK2L-GFP, we can obtain an estimate of Cdk2 kinase activity from individual cells. First, we validated that CDK2L-GFP was a specific reporter of Cdk2 activity in HeLa cells (<xref rid="mmc1" ref-type="supplementary-material">Figures S2</xref>A&#x02013;S2I). As judged by our CDK2L-GFP sensor, Cdk2 kinase activity abruptly increased at S-phase entry, followed by a second phase of activity increase that occurs at a relatively slower rate (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>D; <xref rid="mmc5" ref-type="supplementary-material">Movie S4</xref>). We saw similar behavior if we used the DHB-Ven Cdk2 activity sensor (<xref rid="bib61" ref-type="bibr">Spencer et&#x000a0;al., 2013</xref>) in HeLa cells (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>J). The abrupt increase in kinase activity was precisely correlated with the rapid decrease in p27<sup>Kip1</sup>-GFP (<xref rid="fig1" ref-type="fig">Figures 1</xref>A and 1D), suggesting that degradation of p27<sup>Kip1</sup> may be rate limiting in Cdk2 activation and S-phase entry. Immediately after S-phase entry, we consistently observed a transient decrease in Cdk2 activity (<xref rid="fig1" ref-type="fig">Figures 1</xref>D and <xref rid="mmc1" ref-type="supplementary-material">S2</xref>J). In CyclinE1/2-depleted cells, this decrease is more pronounced (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>D). However, what causes this dip in Cdk2 activity is currently not known and warrants further investigation. Taken together, these observations describe key G1/S signaling events in single cells throughout the G1/S transition.</p></sec><sec id="sec2.2"><title>Developing a Dynamical Model of the G1/S Transition</title><p>To understand how the observed dynamics of Cyclin, CKI and Cdk2 activity emerge from the underlying molecular network, we next generated a dynamical model of the G1/S transition in human cells based on our live imaging data. Until now, the dynamical data necessary to parametrize such a model have not been available, as the current literature provides information only on the molecular mechanisms controlling the G1/S transition (<xref rid="bib31" ref-type="bibr">Kohn, 1999</xref>). This G1/S molecular network involves multiple interactions between Cdk2:CyclinA, Cdk2:CyclinE, p27<sup>Kip1</sup>, and their regulators (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A).</p><p>We have used prior knowledge of the G1/S molecular network to construct a stochastic mathematical model of the G1/S transition (see <xref rid="app2" ref-type="sec">Supplemental Information</xref> for a detailed description of rate expressions). Our model contains a considerable number of kinetic parameters (25) that are largely unknown in the current literature, except for the half-lives of some mRNAs and proteins (<xref rid="bib54" ref-type="bibr">Schwanh&#x000e4;usser et&#x000a0;al., 2011</xref>). The unknown rate constants were estimated by comparing deterministic simulations of the model (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C) with averaged time courses of pseudo-synchronized cell-cycle regulators (<xref rid="fig2" ref-type="fig">Figures 2</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>A) in a brute-force approach.</p><p>In our model, active E2F leads to an accumulation of CyclinE protein early in G1 (<xref rid="fig2" ref-type="fig">Figures 2</xref>C and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>B), in the absence of functional pRb in HeLa cells (<xref rid="bib40" ref-type="bibr">Moody and Laimins, 2010</xref>, <xref rid="bib55" ref-type="bibr">Schwarz et&#x000a0;al., 1985</xref>). However, CyclinE accumulation is insufficient to drive progression into S phase as Cdk2:CyclinE activity is inhibited by its stoichiometric CKI, p27<sup>Kip1</sup>, whose degradation, dependent on Cdk2 and SCF<sup>Skp2</sup> activities (<xref rid="bib57" ref-type="bibr">Sheaff et&#x000a0;al., 1997</xref>), is slow at low Cdk2 activity and low Skp2 levels. Once sufficient CyclinE accumulates, Cdk2:CyclinE activity overcomes p27<sup>Kip1</sup> inhibition. The activated Cdk2:CyclinE targets p27<sup>Kip1</sup> for proteasome-dependent degradation through phosphorylation of T187 on p27<sup>Kip1</sup> (<xref rid="bib42" ref-type="bibr">M&#x000fc;ller et&#x000a0;al., 1997</xref>, <xref rid="bib57" ref-type="bibr">Sheaff et&#x000a0;al., 1997</xref>, <xref rid="bib65" ref-type="bibr">Vlach et&#x000a0;al., 1997</xref>). With the degradation of p27<sup>Kip1</sup>, more Cdk2:CyclinE is released, and p27<sup>Kip1</sup> degradation is further enhanced. The fast positive feedback results in the abrupt degradation of p27<sup>Kip1</sup>. After the abrupt degradation of p27<sup>Kip1</sup>, Cdk2:CyclinE kinase becomes activated (<xref rid="fig2" ref-type="fig">Figures 2</xref>C and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>B).</p><p>In our model, despite the activation of CyclinA protein synthesis, the level of CyclinA is kept low in G1 phase by APC/C<sup>Cdh1</sup>-mediated degradation (<xref rid="fig2" ref-type="fig">Figures 2</xref>C and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>B; <xref rid="bib19" ref-type="bibr">Geley et&#x000a0;al., 2001</xref>, <xref rid="bib35" ref-type="bibr">Lukas et&#x000a0;al., 1999</xref>, <xref rid="bib60" ref-type="bibr">S&#x000f8;rensen et&#x000a0;al., 2001</xref>). Accumulation of CyclinA does not start until inactivation of APC/C<sup>Cdh1</sup>. At the end of G1, APC/C<sup>Cdh1</sup> is inactivated due to the accumulation of Emi1 (<xref rid="bib25" ref-type="bibr">Hsu et&#x000a0;al., 2002</xref>, <xref rid="bib38" ref-type="bibr">Miller et&#x000a0;al., 2006</xref>) and phosphorylation of Cdh1 by Cdk2 (<xref rid="bib28" ref-type="bibr">Keck et&#x000a0;al., 2007</xref>, <xref rid="bib35" ref-type="bibr">Lukas et&#x000a0;al., 1999</xref>). This leads to accumulation of Skp2 (<xref rid="bib2" ref-type="bibr">Bashir et&#x000a0;al., 2004</xref>, <xref rid="bib66" ref-type="bibr">Wei et&#x000a0;al., 2004</xref>). The degradation of phosphorylated p27<sup>Kip1</sup>, which is dependent on SCF<sup>Skp2</sup>-dependent poly-ubiquitylation, is further accelerated by Skp2 accumulation in late G1 (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>C).</p><p>All of these events&#x02014;p27<sup>Kip1</sup> degradation, Cdk2 activation, and CyclinA accumulation&#x02014;coincide with the G1/S transition. This leads to the phosphorylation-dependent degradation of CyclinE protein by Cdk2 (<xref rid="bib68" ref-type="bibr">Won and Reed, 1996</xref>). A linear combination of the model-calculated free Cdk2:Cyclin complexes (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C) therefore approximates the Cdk2 activity, as measured by our Cdk2 sensor (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>B).</p><p>Our model explains the switch-like characteristic of the G1/S transition by mutual inhibition among cell-cycle regulators, with a central role for p27<sup>Kip1</sup>. The abrupt degradation of p27<sup>Kip1</sup> has a critical threshold and fast protein turnover requirement. In our model, the threshold originates from the antagonistic interaction between p27<sup>Kip1</sup> and Cdk2:Cyclin complexes, which creates a bistable switch with the following characteristics. (1) The steady-state level of p27<sup>Kip1</sup> can be either high or low depending on CyclinE levels, but intermediate steady-state levels are unstable (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D). (2) The transition from a high to low p27<sup>Kip1</sup> level takes place at a higher threshold of CyclinE than the opposite transition. Therefore, G1/S control possesses the property of hysteresis. (3) The threshold of CyclinE at which transitions occur is dependent on the levels of Emi1 that inhibit APC/C<sup>Cdh1</sup> and thereby upregulate Skp2 (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D). At the beginning of the cycle when both CyclinE and Emi1 levels are low, the thresholds are high, p27<sup>Kip1</sup> is attracted to the upper steady state, and its level rises (red curve in <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D). (4) During G1, E2F-dependent transcription drives the increase in both CyclinE and Emi1 protein levels. Thus, CyclinE and Emi1 could act synergistically to remove p27<sup>Kip1</sup>. CyclinE levels reach the upper threshold at&#x000a0;a relatively low level of Emi1 that drives the cell through G1/S into a state of low p27<sup>Kip1</sup> (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>D). (5) After the G1/S transition, CyclinE levels start to decrease, but the cell stays in the low p27<sup>Kip1</sup> regime because the thresholds are also decreasing through Emi1 accumulation (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>D). The continuous decrease of the thresholds makes G1/S an irreversible transition in the model.</p><p>Critically, our stochastic model captures the observed dynamics of G1/S regulators in HeLa cells (compare <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>A with S3B) and thus provides a suitable framework by which to make novel predictions regarding the mechanisms that underlie the dynamical nature of the G1/S transition.</p></sec><sec id="sec2.3"><title>Degradation of p27<sup>Kip1</sup> Is Driven by Cdk2 Activity</title><p>Our model of the G1/S regulatory network attributes the abrupt decrease of p27<sup>Kip1</sup> to fast protein turnover regulated by direct and indirect double-negative feedback loops between p27<sup>Kip1</sup> and Cdk2. Specifically, activated Cdk2 promotes p27<sup>Kip1</sup> degradation. Our model also implies that Cdk2 is required to keep the level of p27<sup>Kip1</sup> low after G1/S. Inhibition of Cdk2 should lead to re-accumulation of p27<sup>Kip1</sup> (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>E). To test this prediction, we treated HeLa cells, arrested in early S phase by a thymidine block, with a Cdk1/2 inhibitor. In S-phase-arrested cells, p27<sup>Kip1</sup> levels are negligible. However, upon addition of Cdk1/2 inhibitor, p27<sup>Kip1</sup> rapidly re-accumulated (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>F). This rapid re-accumulation of p27<sup>Kip1</sup> suggests that its synthesis (transcription and translation) is still active during DNA replication. Moreover, the low level of p27<sup>Kip1</sup> after G1/S transition is indeed maintained by high Cdk2 activity promoting p27<sup>Kip1</sup> degradation. Therefore, our model correctly predicts that a low level of p27<sup>Kip1</sup> is maintained throughout S phase by high Cdk activity.</p></sec><sec id="sec2.4"><title>CyclinE Controls the Timing of the G1/S Transition</title><p>Stochastic model simulation with reduced levels of residual CyclinE synthesis suggests that the G1/S transition is delayed if CyclinE levels are depleted in G1 (compare the red and gray p27<sup>Kip1</sup> curves on <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>A). However, the rapid degradation of p27<sup>Kip1</sup> and the abrupt activation of Cdk2 are conserved even after CyclinE depletion. The abruptness of p27<sup>Kip1</sup> degradation in the absence of CyclinE can be attributed to the mutual antagonism between Cdk2:CyclinA and its inhibitor p27<sup>Kip1</sup> (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A). The steady-state level of p27<sup>Kip1</sup> shows a similar Z-shaped dependence on the levels of CyclinA (not shown). The two CyclinA thresholds, where p27<sup>Kip1</sup> decreases or rises, are Emi1 dependent because Emi1 inhibits APC/C<sup>Cdh1</sup> to upregulate Skp2 levels (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B). The model predicts that the &#x0201c;path&#x0201d; during the G1/S transition is different for control siRNA-treated cells (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>D) and CyclinE-depleted cells (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B). In control siRNA cells, CyclinE and Emi1 accumulate simultaneously. Since Emi1 is low, APC/C<sup>Cdh1</sup> is largely active, and Skp2 level is low. Therefore, a large amount of CyclinE is needed&#x000a0;(&#x0003e;0.6 arbitrary units [a.u.]) to trigger p27<sup>Kip1</sup> degradation. In CyclinE-depleted cells, Emi1 accumulates first, leading to&#x000a0;APC/C<sup>Cdh1</sup> inactivation and subsequent accumulation of CyclinA. In the presence of a high level of Emi1, inactive APC/C<sup>Cdh1</sup> and a high level of Skp2, a low level of CyclinA (approximately 0.2 a.u.) is sufficient to trigger p27<sup>Kip1</sup> degradation.</p><p>Consistent with our model prediction, siRNA-mediated depletion of CyclinE delayed the degradation of p27<sup>Kip1</sup>, activation of Cdk2, and initiation of S phase (compare the gray with the red and black curves on <xref rid="fig3" ref-type="fig">Figures 3</xref>C and 3D, respectively; see also <xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>A and S4B). In addition, the abrupt degradation of p27<sup>Kip1</sup> and abrupt activation of Cdk2 remained intact after CyclinE depletion (<xref rid="fig3" ref-type="fig">Figures 3</xref>C and 3D). Together, our results suggest that although CyclinE is dispensable for the initiation of DNA replication (<xref rid="bib21" ref-type="bibr">Geng et&#x000a0;al., 2003</xref>) CyclinE does play a role in the timing the G1/S transition and thus is rate limiting.</p></sec><sec id="sec2.5"><title>CyclinA Is Dispensable for the Timing of G1/S Transition</title><p>Stochastic model simulation with reduced levels of CyclinA suggests no change in the timing of the G1/S transition (compare the red and gray p27 curves on <xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A). In addition, the simulation suggested that neither p27<sup>Kip1</sup> degradation nor Cdk2 activation showed any delay relative to control cells and that these events also kept their close association with the G1/S transition. These simulation results are consistent with our experimental testing, in which CyclinA is depleted by siRNA (compare the gray with the red and black curves on <xref rid="fig4" ref-type="fig">Figures 4</xref>B and 4C, respectively; see also <xref rid="mmc1" ref-type="supplementary-material">Figures S4</xref>A and S4C).</p><p>Since CyclinA does not control the timing of the G1/S transition, the observation that different cells enter S phase at different times is unlikely due to their different levels of CyclinA. Based on our stochastic simulations (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A), we predict that the stochastic expression of other G1/S regulators (for example CyclinE or Emi1) is responsible for the variability in timing of the G1/S transition in CyclinA-deficient cells.</p></sec><sec id="sec2.6"><title>Emi1 Ensures an Irreversible G1/S Transition</title><p>One way to ensure that DNA is replicated once and only once per cell cycle is to make the G1/S transition difficult to reverse. Intuitively, we might predict that by binding and activating Cdk2 CyclinA could maintain an S-phase state after CyclinE is degraded. However, our model simulations predict that CyclinA depletion in S-phase cells is not sufficient to trigger re-accumulation of p27<sup>Kip1</sup> and thus reset cells into G1. In contrast, our model suggests that Emi1 is both necessary and sufficient to maintain the post-G1 state. Specifically, our model predicts that increasing levels of Emi1 during S phase decrease the amount of CyclinE required to maintain p27<sup>Kip1</sup> degradation (<xref rid="fig2" ref-type="fig">Figures 2</xref>D and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>D). If we remove Emi1 from S-phase cells in the model, APC/C<sup>Cdh1</sup> is activated, CyclinA and Skp2 are degraded, and p27<sup>Kip1</sup> and CyclinE re-accumulate. Later, increasing CyclinE causes a second round of p27<sup>Kip1</sup> degradation, and the cells could re-enter S phase once again (<xref rid="fig5" ref-type="fig">Figures 5</xref>A and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>A).</p><p>To test our model prediction, we synchronized cells in early S&#x000a0;phase (with a double thymidine block) and depleted Emi1 by RNA interference during release from the first thymidine block, such that Emi1 would be depleted in the next cell cycle (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>B; see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Experimental Procedures</xref>). Control siRNA-treated cells undergo mitotic cycling, confirmed by fluorescence-activated cell sorting (FACS) (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B) and the temporal patterns of cell-cycle regulators (see <xref rid="mmc1" ref-type="supplementary-material">Figures S5</xref>C&#x02013;S5F). In contrast, Emi1 depletion leads to re-replication of DNA, as previously reported (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B; <xref rid="bib14" ref-type="bibr">Di Fiore and Pines, 2007</xref>, <xref rid="bib36" ref-type="bibr">Machida and Dutta, 2007</xref>). This suggests that Emi1 is required to maintain an irreversible G1/S transition.</p><p>Consistent with our model prediction, the experimental data clearly show a short-lived increase then degradation of CyclinA2-GFP (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C), followed by transient accumulation of p27<sup>Kip1</sup>-GFP (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>D), and re-accumulation of CyclinE1-GFP (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>E). This accumulation of CyclinE1 protein is likely due to a combination of a low level of Cdk2 activity since CyclinE1-GFP is stabilized when Cdk2 activity is inhibited (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>A) and high E2F activity as cells return to a G1-like state. Direct measurements of Cdk2 activity in Emi1-depleted cells show an initial small increase in kinase activity after release from the thymidine block, followed by a decrease. In the majority of cells, this decrease is small and is followed by a plateau in Cdk2 levels at an intermediate level of between 1 and 1.5 (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>F). However, in some cells, this dip in Cdk2 activity is more pronounced. The activity of Cdk2 in any individual Emi1-depleted cell will depend on (1) the level of Emi1 depletion and (2) the relative amounts of CyclinE and CyclinA when Emi1 is depleted in that cell. Therefore, cells with a larger dip in Cdk2 activity may reflect cells with a better Emi1 depletion and/or a higher ratio of CyclinA to CyclinE when Emi1 is depleted.</p><p>This begs the question of how DNA re-replicates after Emi1 depletion. Notably, we do not observe endoreduplication after Emi1 depletion (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B; no discrete peak is seen at 8n; at 200K on the x axis). If we image PCNA dynamics in cells depleted of Emi1, we can observe nuclei switching between G1 and S in the absence of mitosis and nuclei increasing in size (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S6</xref>B; <xref rid="mmc6" ref-type="supplementary-material">Movies S5</xref> and <xref rid="mmc7" ref-type="supplementary-material">S6</xref>). However, PCNA foci in Emi1-depleted cells are not discrete, as in control siRNA-treated cells, and S-phase entry is more noticeable by changes in the &#x0201c;texture&#x0201d; of PCNA localization throughout the nucleus (<xref rid="mmc7" ref-type="supplementary-material">Movie S6</xref>). This implies that after Emi1 depletion, cells do not progress through &#x0201c;early,&#x0201d; &#x0201c;mid,&#x0201d; and &#x0201c;late&#x0201d; DNA replication stages, but instead likely sit at the boundary of G1 and S, refiring some DNA replication origins. Loss of Geminin after Emi1 depletion (<xref rid="bib14" ref-type="bibr">Di Fiore and Pines, 2007</xref>, <xref rid="bib36" ref-type="bibr">Machida and Dutta, 2007</xref>) would permit origin refiring. This is also consistent with recent data suggesting uncontrolled reactivation of replication origins after Emi1 depletion (<xref rid="bib45" ref-type="bibr">Neelsen et&#x000a0;al., 2013</xref>). Altogether, our data suggest that S-phase cells depleted of Emi1 can transiently return to a G1 state (low CyclinA, high p27<sup>Kip1</sup>, accumulating CyclinE) before recommitting to DNA synthesis, supporting our model prediction that Emi1 maintains the irreversibility of the G1/S transition.</p></sec></sec><sec id="sec3"><title>Discussion</title><p>Our model suggests that the abrupt degradation of p27<sup>Kip1</sup> is the result of a rapid proteolytic double-negative feedback loop between Cdk2:CyclinE and p27<sup>Kip1</sup>. This fast degradation of p27<sup>Kip1</sup> ensures a rapid activation of Cdk2 and immediate S-phase entry. We propose that p27<sup>Kip1</sup> degradation is rate limiting in S-phase entry in HeLa cells. Indeed, this is consistent with previous reports using siRNA to deplete p27<sup>Kip1</sup> (<xref rid="bib52" ref-type="bibr">Sabile et&#x000a0;al., 2006</xref>, <xref rid="bib71" ref-type="bibr">Yuan et&#x000a0;al., 2014</xref>). Thus, even though the proteolytic double-negative feedback loop between a Cdk:Cyclin complex and a CKI is embedded within a more complex architecture in HeLa cells than in yeast, it is sufficient to explain the temporally abrupt switching between two discrete cell-cycle states.</p><p>While the feedback between Cdk2:CyclinE and p27<sup>Kip1</sup> is sufficient to explain the switch-like transition between G1 and S&#x000a0;phases, our model predicts that the transition is made globally irreversible by Emi1 accumulation. In support of this, we observe that single S-phase cells depleted of Emi1 re-express p27<sup>Kip1</sup>, accumulate CyclinE, degrade CyclinA, and appear to engage in simultaneous licensing and firing of replication origins, which are normally temporally distinct behaviors (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B). It is also formally possible that Emi1-depleted cells are activating a checkpoint that leads to the stabilization of p27<sup>Kip1</sup>. However, since p27<sup>Kip1</sup> expression is not sustained in the presence of continuous Emi1 depletion and we observe DNA re-replication, we do not think that this is the case.</p><p>In marked contrast to MCF10A and fibroblast cell lines, where populations exhibit heterogeneous Cdk2 dynamics and exist in either Cdk2<sup>high</sup> or Cdk2<sup>low</sup> states (<xref rid="bib61" ref-type="bibr">Spencer et&#x000a0;al., 2013</xref>), HeLa cells are homogeneous in terms of their pattern of Cdk2 activity. HeLa cells lack restriction point control due to expression of E6&#x000a0;and E7 proteins from integrated HPV-18, which inactivate p53 and pRb, respectively (<xref rid="bib4" ref-type="bibr">Boshart et&#x000a0;al., 1984</xref>, <xref rid="bib5" ref-type="bibr">Butz et&#x000a0;al., 1995</xref>) and also overexpress c-Myc (<xref rid="bib16" ref-type="bibr">D&#x000fc;rst et&#x000a0;al., 1987</xref>, <xref rid="bib33" ref-type="bibr">Lazo et&#x000a0;al., 1989</xref>). By extending our model to include pRb control over E2F activity, the differences between HeLa versus MCF10A and fibroblast cell lines can be explained. This suggests that the model may be generalizable to explain some of the differences between cancer and non-transformed cells. In non-transformed cells growing in the presence of intermediate levels of mitogens, the decision between proliferation and G1 arrest is made at the end of the previous cycle (<xref rid="bib47" ref-type="bibr">Overton et&#x000a0;al., 2014</xref>, <xref rid="bib61" ref-type="bibr">Spencer et&#x000a0;al., 2013</xref>). pRb phosphorylation by E2F-induced Cdk2:Cyclin complexes creates additional amplification loops within the network (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A), with low and high Cdk2:CyclinE activity states (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B). Whether dividing cells adopt a Cdk2<sup>high</sup> or Cdk2<sup>low</sup> fate depends on the mutual antagonism between CKIs and the residual Cdk activity after degradation of CyclinA and CyclinB during mitosis. Cdk2:CyclinE activity is the most significant in&#x000a0;this context, and if it is high relative to CKI-mediated inhibition, cells progress into S phase (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C). In the opposite&#x000a0;scenario, high CKI and low Cdk2:CyclinE activity leads to&#x000a0;pRb-dephosphorylation, E2F inactivation, and G1 arrest (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D).</p><p>Perhaps because HeLa cells lack functional pRb, they exist in&#x000a0;a single signaling state that leads to S-phase commitment in&#x000a0;all cells. We suggest that this homogeneity may be an important aspect in oncogenesis, as the lack of bifurcation into CDK<sup>high</sup> or CDK<sup>low</sup> states would ensure that the majority of cells&#x000a0;in a tumor have a high probability of proliferating, resulting in increased tumor fitness. In contrast, if a subpopulation of a&#x000a0;tumor&#x000a0;frequently entered a CDK2<sup>low</sup> state, this would decrease&#x000a0;the fitness of the population as a whole. However, evolving homogeneity in S-phase commitment during oncogenesis may come at a price, as the signaling networks regulating the G1/S transition exist in a single (attractor) region in signaling state space and thus are less robust to inhibition of components necessary for that state. Homogeneity in the signaling state of the G1/S network across cancer cells may explain the somewhat counterintuitive observations that some cancer cells are more dependent on key cell-cycle regulators, such as Cdk2 and CyclinE, than non-transformed cells (<xref rid="bib37" ref-type="bibr">Mart&#x000ed;n et&#x000a0;al., 2005</xref>, <xref rid="bib62" ref-type="bibr">Tetsu and McCormick, 2003</xref>, <xref rid="bib63" ref-type="bibr">van den Heuvel and Harlow, 1993</xref>).</p><p>In future studies, it will be important to determine whether the systems that regulate G1/S are similar in other cancer cell models that lack restriction point control in order to gain mechanistic insight into cell-cycle regulation. Ultimately, different patients may be stratified not only on the basis of genotypic differences, but also on predicted differences in both the architecture and dynamics of their regulatory networks.</p></sec><sec id="sec4"><title>Experimental Procedures</title><sec id="sec4.1"><title>Generation of Fluorescently Tagged BACs and Reporters</title><p>BACs used in this study were ordered from BACPAC Resource center (CHORI). BACs used are p27<sup>Kip1</sup> RP11-70N14, CCNE1 RP11-345J21, and CCNA2 RP11-768B18. All BACs were verified by PCR using verification primers as listed on the Mitocheck website (<ext-link ext-link-type="uri" xlink:href="http://www.mitocheck.org" id="intref0010">http://www.mitocheck.org</ext-link>). Proteins of interest were tagged using BAC Recombineering at their C-termini with localization and affinity purification (LAP) tags that contain GFP and an affinity purification tag (<xref rid="bib51" ref-type="bibr">Poser et&#x000a0;al., 2008</xref>). Primers used to tag BACs were those listed on the Mitocheck BACFinder website (<ext-link ext-link-type="uri" xlink:href="http://www.mitocheck.org/cgi-bin/BACfinder" id="intref0015">http://www.mitocheck.org/cgi-bin/BACfinder</ext-link>). Successful recombination and tagging of genes was confirmed by PCR followed by DNA sequencing.</p><p>PCNA was tagged at the N terminus with the modified LSS2-mKate fluorophore to generate LSS2-mKate-PCNA (<xref rid="bib48" ref-type="bibr">Piatkevich et&#x000a0;al., 2010</xref>).</p><p>To measure CDK2 activity, we used a similar strategy, now described in&#x000a0;<xref rid="bib61" ref-type="bibr">Spencer et&#x000a0;al. (2013)</xref>. We cloned the C-terminal PSLD region of Human DNA Helicase B (DHB; 957-1087 amino acids of DHB) into pIRES-GFP Puro3 to generate CDK2L-GFP. Note that this sensor is slightly longer than that used in Spencer et&#x000a0;al. and is similar to the one first described in <xref rid="bib22" ref-type="bibr">Gu et&#x000a0;al. (2004)</xref>.</p></sec><sec id="sec4.2"><title>Live Cell Imaging</title><p>Live cell imaging was performed using a Zeiss LSM710 confocal, with a 40&#x000d7; oil objective, NA 1.3, or a High-content Opera Spinning disk confocal microscope (PerkinElmer), with a 40&#x000d7; water objective, NA 0.9. All live cell imaging was carried out in a humidified environmental chamber maintained at 37&#x000b0;C and 5% CO<sub>2</sub>.</p></sec><sec id="sec4.3"><title>Quantification of Reporters</title><p>All imaging data was quantified in Volocity (PerkinElmer). To find dynamic changes in GFP intensities, cell nuclei were tracked using the LSS2-mKate-PCNA signal and the Shortest Path algorithm. A maximum distance of 9&#x000a0;&#x003bc;m between nuclei in consecutive timeframes was used to eliminate erroneous tracks. For p27<sup>Kip1</sup>-GFP, CyclinE1-GFP, and CyclinA2-GFP, nuclear levels of protein were quantified since all three proteins had an exclusively nuclear localization during G1 and S. In each cell, the average value of pixel intensities was calculated, and average background fluorescence was subtracted. All fluorescence intensities were normalized to peak levels. Timing of S-phase entry was determined manually from PCNA fluorescence images. Specifically, S-phase entry is defined by a sharp increase in PCNA intensity, often coinciding with the appearance of nucleoli.</p><p>For CDK2L-GFP and DHB-Ven quantification, nuclear intensity was measured by taking a region of interest (ROI) inside the nucleus, and cytoplasmic intensity was measured as the ring region around the nucleus. Cdk2 activity was then measured as the ratio between the ring GFP intensity to the nuclear GFP intensity.</p><p>Additional experimental procedures are provided in <xref rid="app2" ref-type="sec">Supplemental Information</xref>.</p></sec></sec><sec id="sec5"><title>Author Contributions</title><p>A.R.B. designed and performed experiments. A.R.B., F.S.H., T.Z., C.B., and B.N. analyzed the data. T.Z., F.S.H., and B.N. created the mathematical model. A.R.B., F.S.H., T.Z., C.B., and B.N. wrote the paper.</p></sec></body><back><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Asghar</surname><given-names>U.</given-names></name><name><surname>Witkiewicz</surname><given-names>A.K.</given-names></name><name><surname>Turner</surname><given-names>N.C.</given-names></name><name><surname>Knudsen</surname><given-names>E.S.</given-names></name></person-group><article-title>The history and future of targeting cyclin-dependent kinases in cancer therapy</article-title><source>Nat. Rev. Drug Discov.</source><volume>14</volume><year>2015</year><fpage>130</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">25633797</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Bashir</surname><given-names>T.</given-names></name><name><surname>Dorrello</surname><given-names>N.V.</given-names></name><name><surname>Amador</surname><given-names>V.</given-names></name><name><surname>Guardavaccaro</surname><given-names>D.</given-names></name><name><surname>Pagano</surname><given-names>M.</given-names></name></person-group><article-title>Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase</article-title><source>Nature</source><volume>428</volume><year>2004</year><fpage>190</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">15014502</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Bertoli</surname><given-names>C.</given-names></name><name><surname>Skotheim</surname><given-names>J.M.</given-names></name><name><surname>de Bruin</surname><given-names>R.A.</given-names></name></person-group><article-title>Control of cell cycle transcription during G1 and S phases</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>14</volume><year>2013</year><fpage>518</fpage><lpage>528</lpage><pub-id pub-id-type="pmid">23877564</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Boshart</surname><given-names>M.</given-names></name><name><surname>Gissmann</surname><given-names>L.</given-names></name><name><surname>Ikenberg</surname><given-names>H.</given-names></name><name><surname>Kleinheinz</surname><given-names>A.</given-names></name><name><surname>Scheurlen</surname><given-names>W.</given-names></name><name><surname>zur Hausen</surname><given-names>H.</given-names></name></person-group><article-title>A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer</article-title><source>EMBO J.</source><volume>3</volume><year>1984</year><fpage>1151</fpage><lpage>1157</lpage><pub-id pub-id-type="pmid">6329740</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Butz</surname><given-names>K.</given-names></name><name><surname>Shahabeddin</surname><given-names>L.</given-names></name><name><surname>Geisen</surname><given-names>C.</given-names></name><name><surname>Spitkovsky</surname><given-names>D.</given-names></name><name><surname>Ullmann</surname><given-names>A.</given-names></name><name><surname>Hoppe-Seyler</surname><given-names>F.</given-names></name></person-group><article-title>Functional p53 protein in human papillomavirus-positive cancer cells</article-title><source>Oncogene</source><volume>10</volume><year>1995</year><fpage>927</fpage><lpage>936</lpage><pub-id pub-id-type="pmid">7898934</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Carrano</surname><given-names>A.C.</given-names></name><name><surname>Eytan</surname><given-names>E.</given-names></name><name><surname>Hershko</surname><given-names>A.</given-names></name><name><surname>Pagano</surname><given-names>M.</given-names></name></person-group><article-title>SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27</article-title><source>Nat. Cell Biol.</source><volume>1</volume><year>1999</year><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">10559916</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Charvin</surname><given-names>G.</given-names></name><name><surname>Oikonomou</surname><given-names>C.</given-names></name><name><surname>Siggia</surname><given-names>E.D.</given-names></name><name><surname>Cross</surname><given-names>F.R.</given-names></name></person-group><article-title>Origin of irreversibility of cell cycle start in budding yeast</article-title><source>PLoS Biol.</source><volume>8</volume><year>2010</year><fpage>e1000284</fpage><pub-id pub-id-type="pmid">20087409</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K.C.</given-names></name><name><surname>Csikasz-Nagy</surname><given-names>A.</given-names></name><name><surname>Gyorffy</surname><given-names>B.</given-names></name><name><surname>Val</surname><given-names>J.</given-names></name><name><surname>Novak</surname><given-names>B.</given-names></name><name><surname>Tyson</surname><given-names>J.J.</given-names></name></person-group><article-title>Kinetic analysis of a molecular model of the budding yeast cell cycle</article-title><source>Mol. Biol. Cell</source><volume>11</volume><year>2000</year><fpage>369</fpage><lpage>391</lpage><pub-id pub-id-type="pmid">10637314</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>I.M.</given-names></name><name><surname>Hengst</surname><given-names>L.</given-names></name><name><surname>Slingerland</surname><given-names>J.M.</given-names></name></person-group><article-title>The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy</article-title><source>Nat. Rev. Cancer</source><volume>8</volume><year>2008</year><fpage>253</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">18354415</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Ciotta</surname><given-names>G.</given-names></name><name><surname>Hofemeister</surname><given-names>H.</given-names></name><name><surname>Maresca</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name><name><surname>Sarov</surname><given-names>M.</given-names></name><name><surname>Anastassiadis</surname><given-names>K.</given-names></name><name><surname>Stewart</surname><given-names>A.F.</given-names></name></person-group><article-title>Recombineering BAC transgenes for protein tagging</article-title><source>Methods</source><volume>53</volume><year>2011</year><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">20868752</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>F.R.</given-names></name><name><surname>Archambault</surname><given-names>V.</given-names></name><name><surname>Miller</surname><given-names>M.</given-names></name><name><surname>Klovstad</surname><given-names>M.</given-names></name></person-group><article-title>Testing a mathematical model of the yeast cell cycle</article-title><source>Mol. Biol. Cell</source><volume>13</volume><year>2002</year><fpage>52</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11809822</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Cross</surname><given-names>F.R.</given-names></name><name><surname>Buchler</surname><given-names>N.E.</given-names></name><name><surname>Skotheim</surname><given-names>J.M.</given-names></name></person-group><article-title>Evolution of networks and sequences in eukaryotic cell cycle control</article-title><source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source><volume>366</volume><year>2011</year><fpage>3532</fpage><lpage>3544</lpage><pub-id pub-id-type="pmid">22084380</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>den Elzen</surname><given-names>N.</given-names></name><name><surname>Pines</surname><given-names>J.</given-names></name></person-group><article-title>Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase</article-title><source>J.&#x000a0;Cell Biol.</source><volume>153</volume><year>2001</year><fpage>121</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">11285279</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Di Fiore</surname><given-names>B.</given-names></name><name><surname>Pines</surname><given-names>J.</given-names></name></person-group><article-title>Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C</article-title><source>J.&#x000a0;Cell Biol.</source><volume>177</volume><year>2007</year><fpage>425</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">17485488</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Duli&#x00107;</surname><given-names>V.</given-names></name><name><surname>Lees</surname><given-names>E.</given-names></name><name><surname>Reed</surname><given-names>S.I.</given-names></name></person-group><article-title>Association of human cyclin E with a periodic G1-S phase protein kinase</article-title><source>Science</source><volume>257</volume><year>1992</year><fpage>1958</fpage><lpage>1961</lpage><pub-id pub-id-type="pmid">1329201</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>D&#x000fc;rst</surname><given-names>M.</given-names></name><name><surname>Croce</surname><given-names>C.M.</given-names></name><name><surname>Gissmann</surname><given-names>L.</given-names></name><name><surname>Schwarz</surname><given-names>E.</given-names></name><name><surname>Huebner</surname><given-names>K.</given-names></name></person-group><article-title>Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>84</volume><year>1987</year><fpage>1070</fpage><lpage>1074</lpage><pub-id pub-id-type="pmid">3029760</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Essers</surname><given-names>J.</given-names></name><name><surname>Theil</surname><given-names>A.F.</given-names></name><name><surname>Baldeyron</surname><given-names>C.</given-names></name><name><surname>van Cappellen</surname><given-names>W.A.</given-names></name><name><surname>Houtsmuller</surname><given-names>A.B.</given-names></name><name><surname>Kanaar</surname><given-names>R.</given-names></name><name><surname>Vermeulen</surname><given-names>W.</given-names></name></person-group><article-title>Nuclear dynamics of PCNA in DNA replication and repair</article-title><source>Mol. Cell. Biol.</source><volume>25</volume><year>2005</year><fpage>9350</fpage><lpage>9359</lpage><pub-id pub-id-type="pmid">16227586</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Fero</surname><given-names>M.L.</given-names></name><name><surname>Rivkin</surname><given-names>M.</given-names></name><name><surname>Tasch</surname><given-names>M.</given-names></name><name><surname>Porter</surname><given-names>P.</given-names></name><name><surname>Carow</surname><given-names>C.E.</given-names></name><name><surname>Firpo</surname><given-names>E.</given-names></name><name><surname>Polyak</surname><given-names>K.</given-names></name><name><surname>Tsai</surname><given-names>L.H.</given-names></name><name><surname>Broudy</surname><given-names>V.</given-names></name><name><surname>Perlmutter</surname><given-names>R.M.</given-names></name></person-group><article-title>A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice</article-title><source>Cell</source><volume>85</volume><year>1996</year><fpage>733</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">8646781</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Geley</surname><given-names>S.</given-names></name><name><surname>Kramer</surname><given-names>E.</given-names></name><name><surname>Gieffers</surname><given-names>C.</given-names></name><name><surname>Gannon</surname><given-names>J.</given-names></name><name><surname>Peters</surname><given-names>J.M.</given-names></name><name><surname>Hunt</surname><given-names>T.</given-names></name></person-group><article-title>Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint</article-title><source>J.&#x000a0;Cell Biol.</source><volume>153</volume><year>2001</year><fpage>137</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">11285280</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>Y.</given-names></name><name><surname>Eaton</surname><given-names>E.N.</given-names></name><name><surname>Pic&#x000f3;n</surname><given-names>M.</given-names></name><name><surname>Roberts</surname><given-names>J.M.</given-names></name><name><surname>Lundberg</surname><given-names>A.S.</given-names></name><name><surname>Gifford</surname><given-names>A.</given-names></name><name><surname>Sardet</surname><given-names>C.</given-names></name><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>Regulation of cyclin E transcription by E2Fs and retinoblastoma protein</article-title><source>Oncogene</source><volume>12</volume><year>1996</year><fpage>1173</fpage><lpage>1180</lpage><pub-id pub-id-type="pmid">8649818</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Geng</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>Q.</given-names></name><name><surname>Sicinska</surname><given-names>E.</given-names></name><name><surname>Das</surname><given-names>M.</given-names></name><name><surname>Schneider</surname><given-names>J.E.</given-names></name><name><surname>Bhattacharya</surname><given-names>S.</given-names></name><name><surname>Rideout</surname><given-names>W.M.</given-names></name><name><surname>Bronson</surname><given-names>R.T.</given-names></name><name><surname>Gardner</surname><given-names>H.</given-names></name><name><surname>Sicinski</surname><given-names>P.</given-names></name></person-group><article-title>Cyclin E ablation in the mouse</article-title><source>Cell</source><volume>114</volume><year>2003</year><fpage>431</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">12941272</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Xia</surname><given-names>X.</given-names></name><name><surname>Yan</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Podust</surname><given-names>V.N.</given-names></name><name><surname>Reynolds</surname><given-names>A.B.</given-names></name><name><surname>Fanning</surname><given-names>E.</given-names></name></person-group><article-title>Cell cycle-dependent regulation of a human DNA helicase that localizes in DNA damage foci</article-title><source>Mol. Biol. Cell</source><volume>15</volume><year>2004</year><fpage>3320</fpage><lpage>3332</lpage><pub-id pub-id-type="pmid">15146062</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Held</surname><given-names>M.</given-names></name><name><surname>Schmitz</surname><given-names>M.H.</given-names></name><name><surname>Fischer</surname><given-names>B.</given-names></name><name><surname>Walter</surname><given-names>T.</given-names></name><name><surname>Neumann</surname><given-names>B.</given-names></name><name><surname>Olma</surname><given-names>M.H.</given-names></name><name><surname>Peter</surname><given-names>M.</given-names></name><name><surname>Ellenberg</surname><given-names>J.</given-names></name><name><surname>Gerlich</surname><given-names>D.W.</given-names></name></person-group><article-title>CellCognition: time-resolved phenotype annotation in high-throughput live cell imaging</article-title><source>Nat. Methods</source><volume>7</volume><year>2010</year><fpage>747</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">20693996</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Hershko</surname><given-names>D.D.</given-names></name></person-group><article-title>Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target</article-title><source>Future Oncol.</source><volume>6</volume><year>2010</year><fpage>1837</fpage><lpage>1847</lpage><pub-id pub-id-type="pmid">21142858</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>J.Y.</given-names></name><name><surname>Reimann</surname><given-names>J.D.</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>C.S.</given-names></name><name><surname>Lukas</surname><given-names>J.</given-names></name><name><surname>Jackson</surname><given-names>P.K.</given-names></name></person-group><article-title>E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1)</article-title><source>Nat. Cell Biol.</source><volume>4</volume><year>2002</year><fpage>358</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">11988738</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Hutchins</surname><given-names>J.R.</given-names></name><name><surname>Toyoda</surname><given-names>Y.</given-names></name><name><surname>Hegemann</surname><given-names>B.</given-names></name><name><surname>Poser</surname><given-names>I.</given-names></name><name><surname>H&#x000e9;rich&#x000e9;</surname><given-names>J.K.</given-names></name><name><surname>Sykora</surname><given-names>M.M.</given-names></name><name><surname>Augsburg</surname><given-names>M.</given-names></name><name><surname>Hudecz</surname><given-names>O.</given-names></name><name><surname>Buschhorn</surname><given-names>B.A.</given-names></name><name><surname>Bulkescher</surname><given-names>J.</given-names></name></person-group><article-title>Systematic analysis of human protein complexes identifies chromosome segregation proteins</article-title><source>Science</source><volume>328</volume><year>2010</year><fpage>593</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">20360068</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>A.</given-names></name><name><surname>Skotheim</surname><given-names>J.M.</given-names></name></person-group><article-title>Start and the restriction point</article-title><source>Curr. Opin. Cell Biol.</source><volume>25</volume><year>2013</year><fpage>717</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">23916770</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Keck</surname><given-names>J.M.</given-names></name><name><surname>Summers</surname><given-names>M.K.</given-names></name><name><surname>Tedesco</surname><given-names>D.</given-names></name><name><surname>Ekholm-Reed</surname><given-names>S.</given-names></name><name><surname>Chuang</surname><given-names>L.C.</given-names></name><name><surname>Jackson</surname><given-names>P.K.</given-names></name><name><surname>Reed</surname><given-names>S.I.</given-names></name></person-group><article-title>Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1)</article-title><source>J.&#x000a0;Cell Biol.</source><volume>178</volume><year>2007</year><fpage>371</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">17664332</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Kiyokawa</surname><given-names>H.</given-names></name><name><surname>Kineman</surname><given-names>R.D.</given-names></name><name><surname>Manova-Todorova</surname><given-names>K.O.</given-names></name><name><surname>Soares</surname><given-names>V.C.</given-names></name><name><surname>Hoffman</surname><given-names>E.S.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><name><surname>Khanam</surname><given-names>D.</given-names></name><name><surname>Hayday</surname><given-names>A.C.</given-names></name><name><surname>Frohman</surname><given-names>L.A.</given-names></name><name><surname>Koff</surname><given-names>A.</given-names></name></person-group><article-title>Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)</article-title><source>Cell</source><volume>85</volume><year>1996</year><fpage>721</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">8646780</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Koff</surname><given-names>A.</given-names></name><name><surname>Giordano</surname><given-names>A.</given-names></name><name><surname>Desai</surname><given-names>D.</given-names></name><name><surname>Yamashita</surname><given-names>K.</given-names></name><name><surname>Harper</surname><given-names>J.W.</given-names></name><name><surname>Elledge</surname><given-names>S.</given-names></name><name><surname>Nishimoto</surname><given-names>T.</given-names></name><name><surname>Morgan</surname><given-names>D.O.</given-names></name><name><surname>Franza</surname><given-names>B.R.</given-names></name><name><surname>Roberts</surname><given-names>J.M.</given-names></name></person-group><article-title>Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle</article-title><source>Science</source><volume>257</volume><year>1992</year><fpage>1689</fpage><lpage>1694</lpage><pub-id pub-id-type="pmid">1388288</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Kohn</surname><given-names>K.W.</given-names></name></person-group><article-title>Molecular interaction map of the mammalian cell cycle control and DNA repair systems</article-title><source>Mol. Biol. Cell</source><volume>10</volume><year>1999</year><fpage>2703</fpage><lpage>2734</lpage><pub-id pub-id-type="pmid">10436023</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>K&#x000f5;ivom&#x000e4;gi</surname><given-names>M.</given-names></name><name><surname>Valk</surname><given-names>E.</given-names></name><name><surname>Venta</surname><given-names>R.</given-names></name><name><surname>Iofik</surname><given-names>A.</given-names></name><name><surname>Lepiku</surname><given-names>M.</given-names></name><name><surname>Balog</surname><given-names>E.R.</given-names></name><name><surname>Rubin</surname><given-names>S.M.</given-names></name><name><surname>Morgan</surname><given-names>D.O.</given-names></name><name><surname>Loog</surname><given-names>M.</given-names></name></person-group><article-title>Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase</article-title><source>Nature</source><volume>480</volume><year>2011</year><fpage>128</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">21993622</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Lazo</surname><given-names>P.A.</given-names></name><name><surname>DiPaolo</surname><given-names>J.A.</given-names></name><name><surname>Popescu</surname><given-names>N.C.</given-names></name></person-group><article-title>Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5&#x02032;-flanking cellular sequence located near the myc protooncogene in HeLa cells</article-title><source>Cancer Res.</source><volume>49</volume><year>1989</year><fpage>4305</fpage><lpage>4310</lpage><pub-id pub-id-type="pmid">2545339</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Leonhardt</surname><given-names>H.</given-names></name><name><surname>Rahn</surname><given-names>H.P.</given-names></name><name><surname>Weinzierl</surname><given-names>P.</given-names></name><name><surname>Sporbert</surname><given-names>A.</given-names></name><name><surname>Cremer</surname><given-names>T.</given-names></name><name><surname>Zink</surname><given-names>D.</given-names></name><name><surname>Cardoso</surname><given-names>M.C.</given-names></name></person-group><article-title>Dynamics of DNA replication factories in living cells</article-title><source>J.&#x000a0;Cell Biol.</source><volume>149</volume><year>2000</year><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">10769021</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Lukas</surname><given-names>C.</given-names></name><name><surname>S&#x000f8;rensen</surname><given-names>C.S.</given-names></name><name><surname>Kramer</surname><given-names>E.</given-names></name><name><surname>Santoni-Rugiu</surname><given-names>E.</given-names></name><name><surname>Lindeneg</surname><given-names>C.</given-names></name><name><surname>Peters</surname><given-names>J.M.</given-names></name><name><surname>Bartek</surname><given-names>J.</given-names></name><name><surname>Lukas</surname><given-names>J.</given-names></name></person-group><article-title>Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex</article-title><source>Nature</source><volume>401</volume><year>1999</year><fpage>815</fpage><lpage>818</lpage><pub-id pub-id-type="pmid">10548110</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Machida</surname><given-names>Y.J.</given-names></name><name><surname>Dutta</surname><given-names>A.</given-names></name></person-group><article-title>The APC/C inhibitor, Emi1, is essential for prevention of rereplication</article-title><source>Genes Dev.</source><volume>21</volume><year>2007</year><fpage>184</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">17234884</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n</surname><given-names>A.</given-names></name><name><surname>Odajima</surname><given-names>J.</given-names></name><name><surname>Hunt</surname><given-names>S.L.</given-names></name><name><surname>Dubus</surname><given-names>P.</given-names></name><name><surname>Ortega</surname><given-names>S.</given-names></name><name><surname>Malumbres</surname><given-names>M.</given-names></name><name><surname>Barbacid</surname><given-names>M.</given-names></name></person-group><article-title>Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1)</article-title><source>Cancer Cell</source><volume>7</volume><year>2005</year><fpage>591</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">15950907</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J.J.</given-names></name><name><surname>Summers</surname><given-names>M.K.</given-names></name><name><surname>Hansen</surname><given-names>D.V.</given-names></name><name><surname>Nachury</surname><given-names>M.V.</given-names></name><name><surname>Lehman</surname><given-names>N.L.</given-names></name><name><surname>Loktev</surname><given-names>A.</given-names></name><name><surname>Jackson</surname><given-names>P.K.</given-names></name></person-group><article-title>Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor</article-title><source>Genes Dev.</source><volume>20</volume><year>2006</year><fpage>2410</fpage><lpage>2420</lpage><pub-id pub-id-type="pmid">16921029</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Montagnoli</surname><given-names>A.</given-names></name><name><surname>Fiore</surname><given-names>F.</given-names></name><name><surname>Eytan</surname><given-names>E.</given-names></name><name><surname>Carrano</surname><given-names>A.C.</given-names></name><name><surname>Draetta</surname><given-names>G.F.</given-names></name><name><surname>Hershko</surname><given-names>A.</given-names></name><name><surname>Pagano</surname><given-names>M.</given-names></name></person-group><article-title>Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation</article-title><source>Genes Dev.</source><volume>13</volume><year>1999</year><fpage>1181</fpage><lpage>1189</lpage><pub-id pub-id-type="pmid">10323868</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Moody</surname><given-names>C.A.</given-names></name><name><surname>Laimins</surname><given-names>L.A.</given-names></name></person-group><article-title>Human papillomavirus oncoproteins: pathways to transformation</article-title><source>Nat. Rev. Cancer</source><volume>10</volume><year>2010</year><fpage>550</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">20592731</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>D.O.</given-names></name></person-group><article-title>Cyclin-dependent kinases: engines, clocks, and microprocessors</article-title><source>Annu. Rev. Cell Dev. Biol.</source><volume>13</volume><year>1997</year><fpage>261</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">9442875</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>D.</given-names></name><name><surname>Bouchard</surname><given-names>C.</given-names></name><name><surname>Rudolph</surname><given-names>B.</given-names></name><name><surname>Steiner</surname><given-names>P.</given-names></name><name><surname>Stuckmann</surname><given-names>I.</given-names></name><name><surname>Saffrich</surname><given-names>R.</given-names></name><name><surname>Ansorge</surname><given-names>W.</given-names></name><name><surname>Huttner</surname><given-names>W.</given-names></name><name><surname>Eilers</surname><given-names>M.</given-names></name></person-group><article-title>Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes</article-title><source>Oncogene</source><volume>15</volume><year>1997</year><fpage>2561</fpage><lpage>2576</lpage><pub-id pub-id-type="pmid">9399644</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>K.</given-names></name><name><surname>Ishida</surname><given-names>N.</given-names></name><name><surname>Shirane</surname><given-names>M.</given-names></name><name><surname>Inomata</surname><given-names>A.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Shishido</surname><given-names>N.</given-names></name><name><surname>Horii</surname><given-names>I.</given-names></name><name><surname>Loh</surname><given-names>D.Y.</given-names></name><name><surname>Nakayama</surname><given-names>K.</given-names></name></person-group><article-title>Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors</article-title><source>Cell</source><volume>85</volume><year>1996</year><fpage>707</fpage><lpage>720</lpage><pub-id pub-id-type="pmid">8646779</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Nash</surname><given-names>P.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Orlicky</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Gertler</surname><given-names>F.B.</given-names></name><name><surname>Mendenhall</surname><given-names>M.D.</given-names></name><name><surname>Sicheri</surname><given-names>F.</given-names></name><name><surname>Pawson</surname><given-names>T.</given-names></name><name><surname>Tyers</surname><given-names>M.</given-names></name></person-group><article-title>Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication</article-title><source>Nature</source><volume>414</volume><year>2001</year><fpage>514</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">11734846</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Neelsen</surname><given-names>K.J.</given-names></name><name><surname>Zanini</surname><given-names>I.M.</given-names></name><name><surname>Mijic</surname><given-names>S.</given-names></name><name><surname>Herrador</surname><given-names>R.</given-names></name><name><surname>Zellweger</surname><given-names>R.</given-names></name><name><surname>Ray Chaudhuri</surname><given-names>A.</given-names></name><name><surname>Creavin</surname><given-names>K.D.</given-names></name><name><surname>Blow</surname><given-names>J.J.</given-names></name><name><surname>Lopes</surname><given-names>M.</given-names></name></person-group><article-title>Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template</article-title><source>Genes Dev.</source><volume>27</volume><year>2013</year><fpage>2537</fpage><lpage>2542</lpage><pub-id pub-id-type="pmid">24298053</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Ohtani</surname><given-names>K.</given-names></name><name><surname>DeGregori</surname><given-names>J.</given-names></name><name><surname>Nevins</surname><given-names>J.R.</given-names></name></person-group><article-title>Regulation of the cyclin E gene by transcription factor E2F1</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>92</volume><year>1995</year><fpage>12146</fpage><lpage>12150</lpage><pub-id pub-id-type="pmid">8618861</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Overton</surname><given-names>K.W.</given-names></name><name><surname>Spencer</surname><given-names>S.L.</given-names></name><name><surname>Noderer</surname><given-names>W.L.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>C.L.</given-names></name></person-group><article-title>Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>111</volume><year>2014</year><fpage>E4386</fpage><lpage>E4393</lpage><pub-id pub-id-type="pmid">25267623</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Piatkevich</surname><given-names>K.D.</given-names></name><name><surname>Hulit</surname><given-names>J.</given-names></name><name><surname>Subach</surname><given-names>O.M.</given-names></name><name><surname>Wu</surname><given-names>B.</given-names></name><name><surname>Abdulla</surname><given-names>A.</given-names></name><name><surname>Segall</surname><given-names>J.E.</given-names></name><name><surname>Verkhusha</surname><given-names>V.V.</given-names></name></person-group><article-title>Monomeric red fluorescent proteins with a large Stokes shift</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>107</volume><year>2010</year><fpage>5369</fpage><lpage>5374</lpage><pub-id pub-id-type="pmid">20212155</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Pines</surname><given-names>J.</given-names></name><name><surname>Hunter</surname><given-names>T.</given-names></name></person-group><article-title>Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B</article-title><source>Nature</source><volume>346</volume><year>1990</year><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="pmid">2143810</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Pomerening</surname><given-names>J.R.</given-names></name><name><surname>Ubersax</surname><given-names>J.A.</given-names></name><name><surname>Ferrell</surname><given-names>J.E.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Rapid cycling and precocious termination of G1 phase in cells expressing CDK1AF</article-title><source>Mol. Biol. Cell</source><volume>19</volume><year>2008</year><fpage>3426</fpage><lpage>3441</lpage><pub-id pub-id-type="pmid">18480403</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Poser</surname><given-names>I.</given-names></name><name><surname>Sarov</surname><given-names>M.</given-names></name><name><surname>Hutchins</surname><given-names>J.R.</given-names></name><name><surname>H&#x000e9;rich&#x000e9;</surname><given-names>J.K.</given-names></name><name><surname>Toyoda</surname><given-names>Y.</given-names></name><name><surname>Pozniakovsky</surname><given-names>A.</given-names></name><name><surname>Weigl</surname><given-names>D.</given-names></name><name><surname>Nitzsche</surname><given-names>A.</given-names></name><name><surname>Hegemann</surname><given-names>B.</given-names></name><name><surname>Bird</surname><given-names>A.W.</given-names></name></person-group><article-title>BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals</article-title><source>Nat. Methods</source><volume>5</volume><year>2008</year><fpage>409</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">18391959</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Sabile</surname><given-names>A.</given-names></name><name><surname>Meyer</surname><given-names>A.M.</given-names></name><name><surname>Wirbelauer</surname><given-names>C.</given-names></name><name><surname>Hess</surname><given-names>D.</given-names></name><name><surname>Kogel</surname><given-names>U.</given-names></name><name><surname>Scheffner</surname><given-names>M.</given-names></name><name><surname>Krek</surname><given-names>W.</given-names></name></person-group><article-title>Regulation of p27 degradation and S-phase progression by Ro52 RING finger protein</article-title><source>Mol. Cell. Biol.</source><volume>26</volume><year>2006</year><fpage>5994</fpage><lpage>6004</lpage><pub-id pub-id-type="pmid">16880511</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Scaltriti</surname><given-names>M.</given-names></name><name><surname>Eichhorn</surname><given-names>P.J.</given-names></name><name><surname>Cort&#x000e9;s</surname><given-names>J.</given-names></name><name><surname>Prudkin</surname><given-names>L.</given-names></name><name><surname>Aura</surname><given-names>C.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>Chandarlapaty</surname><given-names>S.</given-names></name><name><surname>Serra</surname><given-names>V.</given-names></name><name><surname>Prat</surname><given-names>A.</given-names></name><name><surname>Ibrahim</surname><given-names>Y.H.</given-names></name></person-group><article-title>Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>108</volume><year>2011</year><fpage>3761</fpage><lpage>3766</lpage><pub-id pub-id-type="pmid">21321214</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Schwanh&#x000e4;usser</surname><given-names>B.</given-names></name><name><surname>Busse</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Dittmar</surname><given-names>G.</given-names></name><name><surname>Schuchhardt</surname><given-names>J.</given-names></name><name><surname>Wolf</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Selbach</surname><given-names>M.</given-names></name></person-group><article-title>Global quantification of mammalian gene expression control</article-title><source>Nature</source><volume>473</volume><year>2011</year><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">21593866</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>E.</given-names></name><name><surname>Freese</surname><given-names>U.K.</given-names></name><name><surname>Gissmann</surname><given-names>L.</given-names></name><name><surname>Mayer</surname><given-names>W.</given-names></name><name><surname>Roggenbuck</surname><given-names>B.</given-names></name><name><surname>Stremlau</surname><given-names>A.</given-names></name><name><surname>zur Hausen</surname><given-names>H.</given-names></name></person-group><article-title>Structure and transcription of human papillomavirus sequences in cervical carcinoma cells</article-title><source>Nature</source><volume>314</volume><year>1985</year><fpage>111</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">2983228</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Schwob</surname><given-names>E.</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>T.</given-names></name><name><surname>Mendenhall</surname><given-names>M.D.</given-names></name><name><surname>Nasmyth</surname><given-names>K.</given-names></name></person-group><article-title>The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae</article-title><source>Cell</source><volume>79</volume><year>1994</year><fpage>233</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">7954792</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Sheaff</surname><given-names>R.J.</given-names></name><name><surname>Groudine</surname><given-names>M.</given-names></name><name><surname>Gordon</surname><given-names>M.</given-names></name><name><surname>Roberts</surname><given-names>J.M.</given-names></name><name><surname>Clurman</surname><given-names>B.E.</given-names></name></person-group><article-title>Cyclin E-CDK2 is a regulator of p27Kip1</article-title><source>Genes Dev.</source><volume>11</volume><year>1997</year><fpage>1464</fpage><lpage>1478</lpage><pub-id pub-id-type="pmid">9192873</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Sherr</surname><given-names>C.J.</given-names></name><name><surname>Roberts</surname><given-names>J.M.</given-names></name></person-group><article-title>CDK inhibitors: positive and negative regulators of G1-phase progression</article-title><source>Genes Dev.</source><volume>13</volume><year>1999</year><fpage>1501</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">10385618</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal" id="sref59"><person-group person-group-type="author"><name><surname>Skotheim</surname><given-names>J.M.</given-names></name><name><surname>Di Talia</surname><given-names>S.</given-names></name><name><surname>Siggia</surname><given-names>E.D.</given-names></name><name><surname>Cross</surname><given-names>F.R.</given-names></name></person-group><article-title>Positive feedback of G1 cyclins ensures coherent cell cycle entry</article-title><source>Nature</source><volume>454</volume><year>2008</year><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">18633409</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal" id="sref60"><person-group person-group-type="author"><name><surname>S&#x000f8;rensen</surname><given-names>C.S.</given-names></name><name><surname>Lukas</surname><given-names>C.</given-names></name><name><surname>Kramer</surname><given-names>E.R.</given-names></name><name><surname>Peters</surname><given-names>J.M.</given-names></name><name><surname>Bartek</surname><given-names>J.</given-names></name><name><surname>Lukas</surname><given-names>J.</given-names></name></person-group><article-title>A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression</article-title><source>Mol. Cell. Biol.</source><volume>21</volume><year>2001</year><fpage>3692</fpage><lpage>3703</lpage><pub-id pub-id-type="pmid">11340163</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal" id="sref61"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>S.L.</given-names></name><name><surname>Cappell</surname><given-names>S.D.</given-names></name><name><surname>Tsai</surname><given-names>F.C.</given-names></name><name><surname>Overton</surname><given-names>K.W.</given-names></name><name><surname>Wang</surname><given-names>C.L.</given-names></name><name><surname>Meyer</surname><given-names>T.</given-names></name></person-group><article-title>The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit</article-title><source>Cell</source><volume>155</volume><year>2013</year><fpage>369</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">24075009</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal" id="sref62"><person-group person-group-type="author"><name><surname>Tetsu</surname><given-names>O.</given-names></name><name><surname>McCormick</surname><given-names>F.</given-names></name></person-group><article-title>Proliferation of cancer cells despite CDK2 inhibition</article-title><source>Cancer Cell</source><volume>3</volume><year>2003</year><fpage>233</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">12676582</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal" id="sref63"><person-group person-group-type="author"><name><surname>van den Heuvel</surname><given-names>S.</given-names></name><name><surname>Harlow</surname><given-names>E.</given-names></name></person-group><article-title>Distinct roles for cyclin-dependent kinases in cell cycle control</article-title><source>Science</source><volume>262</volume><year>1993</year><fpage>2050</fpage><lpage>2054</lpage><pub-id pub-id-type="pmid">8266103</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal" id="sref64"><person-group person-group-type="author"><name><surname>Verdugo</surname><given-names>A.</given-names></name><name><surname>Vinod</surname><given-names>P.K.</given-names></name><name><surname>Tyson</surname><given-names>J.J.</given-names></name><name><surname>Novak</surname><given-names>B.</given-names></name></person-group><article-title>Molecular mechanisms creating bistable switches at cell cycle transitions</article-title><source>Open Biol.</source><volume>3</volume><year>2013</year><fpage>120179</fpage><pub-id pub-id-type="pmid">23486222</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal" id="sref65"><person-group person-group-type="author"><name><surname>Vlach</surname><given-names>J.</given-names></name><name><surname>Hennecke</surname><given-names>S.</given-names></name><name><surname>Amati</surname><given-names>B.</given-names></name></person-group><article-title>Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27</article-title><source>EMBO J.</source><volume>16</volume><year>1997</year><fpage>5334</fpage><lpage>5344</lpage><pub-id pub-id-type="pmid">9311993</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal" id="sref66"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Ayad</surname><given-names>N.G.</given-names></name><name><surname>Wan</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>G.J.</given-names></name><name><surname>Kirschner</surname><given-names>M.W.</given-names></name><name><surname>Kaelin</surname><given-names>W.G.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex</article-title><source>Nature</source><volume>428</volume><year>2004</year><fpage>194</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">15014503</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal" id="sref67"><person-group person-group-type="author"><name><surname>Weinberg</surname><given-names>R.A.</given-names></name></person-group><article-title>The retinoblastoma protein and cell cycle control</article-title><source>Cell</source><volume>81</volume><year>1995</year><fpage>323</fpage><lpage>330</lpage><pub-id pub-id-type="pmid">7736585</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal" id="sref68"><person-group person-group-type="author"><name><surname>Won</surname><given-names>K.A.</given-names></name><name><surname>Reed</surname><given-names>S.I.</given-names></name></person-group><article-title>Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E</article-title><source>EMBO J.</source><volume>15</volume><year>1996</year><fpage>4182</fpage><lpage>4193</lpage><pub-id pub-id-type="pmid">8861947</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal" id="sref69"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Lau</surname><given-names>K.Y.</given-names></name><name><surname>Sevim</surname><given-names>V.</given-names></name><name><surname>Tang</surname><given-names>C.</given-names></name></person-group><article-title>Design principles of the yeast G1/S switch</article-title><source>PLoS Biol.</source><volume>11</volume><year>2013</year><fpage>e1001673</fpage><pub-id pub-id-type="pmid">24130459</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal" id="sref70"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>T.J.</given-names></name><name><surname>Mori</surname><given-names>S.</given-names></name><name><surname>Nevins</surname><given-names>J.R.</given-names></name><name><surname>You</surname><given-names>L.</given-names></name></person-group><article-title>A bistable Rb-E2F switch underlies the restriction point</article-title><source>Nat. Cell Biol.</source><volume>10</volume><year>2008</year><fpage>476</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">18364697</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal" id="sref71"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>Srividhya</surname><given-names>J.</given-names></name><name><surname>De Luca</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Pomerening</surname><given-names>J.R.</given-names></name></person-group><article-title>Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset</article-title><source>Mol. Biol. Cell</source><volume>25</volume><year>2014</year><fpage>441</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">24356446</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal" id="sref72"><person-group person-group-type="author"><name><surname>Zachariae</surname><given-names>W.</given-names></name><name><surname>Schwab</surname><given-names>M.</given-names></name><name><surname>Nasmyth</surname><given-names>K.</given-names></name><name><surname>Seufert</surname><given-names>W.</given-names></name></person-group><article-title>Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex</article-title><source>Science</source><volume>282</volume><year>1998</year><fpage>1721</fpage><lpage>1724</lpage><pub-id pub-id-type="pmid">9831566</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal" id="sref73"><person-group person-group-type="author"><name><surname>Zetterberg</surname><given-names>A.</given-names></name><name><surname>Larsson</surname><given-names>O.</given-names></name><name><surname>Wiman</surname><given-names>K.G.</given-names></name></person-group><article-title>What is the restriction point?</article-title><source>Curr. Opin. Cell Biol.</source><volume>7</volume><year>1995</year><fpage>835</fpage><lpage>842</lpage><pub-id pub-id-type="pmid">8608014</pub-id></element-citation></ref></ref-list><sec id="app2" sec-type="supplementary-material"><title>Supplemental Information</title><p><supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Supplemental Experimental Procedures and Figures S1&#x02013;S6</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material><supplementary-material content-type="local-data" id="mmc2"><caption><title>Movie S1. p27Kip1-GFP/LSS2-mKate PCNA Expressing HeLa Cells, Related to Figure&#x000a0;1A</title></caption><media xlink:href="mmc2.jpg"/></supplementary-material><supplementary-material content-type="local-data" id="mmc3"><caption><title>Movie S2. CyclinE1-GFP/LSS2-mKate PCNA Expressing HeLa Cells, Related to Figure&#x000a0;1B</title></caption><media xlink:href="mmc3.jpg"/></supplementary-material><supplementary-material content-type="local-data" id="mmc4"><caption><title>Movie S3. CyclinA2-GFP/LSS2-mKate PCNA Expressing HeLa Cells, Related to Figure&#x000a0;1E</title></caption><media xlink:href="mmc4.jpg"/></supplementary-material><supplementary-material content-type="local-data" id="mmc5"><caption><title>Movie S4. CDK2L-GFP/LSS2-mKate PCNA Expressing HeLa Cells, Related to Figure&#x000a0;1D</title></caption><media xlink:href="mmc5.jpg"/></supplementary-material><supplementary-material content-type="local-data" id="mmc6"><caption><title>Movie S5. GFP-PCNA Expressing HeLa Cells, Related to Figure&#x000a0;S6B</title></caption><media xlink:href="mmc6.jpg"/></supplementary-material><supplementary-material content-type="local-data" id="mmc7"><caption><title>Movie S6. GFP-PCNA-Expressing HeLa Cells Treated with Emi1 siRNA, Related to Figure&#x000a0;S6B</title></caption><media xlink:href="mmc7.jpg"/></supplementary-material><supplementary-material content-type="local-data" id="mmc8"><caption><title>Document S2. Article plus Supplemental Information</title></caption><media xlink:href="mmc8.pdf"/></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>We thank Faraz Mardakheh and Rebecca Wilson for technical help. We thank Francis Barr and Jonathon Pines for critical reading of the manuscript. We thank Ellen Fanning (Vanderbilt-Ingram Cancer Center), Cristina Cardoso (Technische Universitat), Vladislav Verkhusha (Albert Einstein College of Medicine), Tobias Meyer (Stanford University), and Spiros Linardopoulos (Institute of Cancer Research) for reagents. The groups of C.B. and B.N. are supported by BBSRC Strategic LoLa grant (BB/MM00354X/1).</p></ack><fn-group><fn id="d32e199"><p id="ccnp0005">This is an open access article under the CC BY license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" id="ccintref0005">http://creativecommons.org/licenses/by/4.0/</ext-link>).</p></fn><fn id="app1" fn-type="supplementary-material"><p>Supplemental Information includes Supplemental Experimental Procedures, six figures, and six movies and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.cels.2016.01.001" id="intref0020">http://dx.doi.org/10.1016/j.cels.2016.01.001</ext-link>.</p></fn></fn-group></back><floats-group><fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Quantifying the Dynamics of G1/S Regulators in Single Cells</p><p>(A) Stills taken from <xref rid="mmc2" ref-type="supplementary-material">Movie S1</xref> of HeLa cells stably expressing p27<sup>Kip1</sup>-GFP and LSS2-mKate-PCNA. Graph shows quantification of p27<sup>Kip1</sup>-GFP from individual cells, aligned to the G1/S transition. Four independent measurements were taken, and 17 cells from one experiment are shown.</p><p>(B) Stills taken from <xref rid="mmc3" ref-type="supplementary-material">Movie S2</xref> of HeLa cells stably expressing CyclinE1-GFP and LSS2-mKate-PCNA. Graph shows quantification of CyclinE1-GFP from individual cells, aligned to the G1/S transition. Three independent measurements were taken, and 15 cells from one experiment are shown.</p><p>(C) Stills taken from <xref rid="mmc4" ref-type="supplementary-material">Movie S3</xref> of HeLa cells stably expressing CyclinA2-GFP and LSS2-mKate-PCNA. Graph shows quantification of Cyclin A2-GFP from individual cells, aligned to the G1/S transition. Four independent measurements were taken, and 11 cells from one experiment are shown.</p><p>(D) Stills taken from <xref rid="mmc5" ref-type="supplementary-material">Movie S4</xref> of HeLa cells stably expressing the CDK2 sensor and LSS2-mKate-PCNA. Graph shows quantification of CDK2 activity from individual cells, aligned to the G1/S transition. Three independent measurements were taken, and nine cells from one experiment are shown. In all cases, each curve is an individual cell. Time on images is shown in minutes and on graphs is shown in hours. Background shading on the graphs shows G1 in red and S phase in green. Scale bars, 10&#x000a0;&#x003bc;m.</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Dynamics of the G1/S Transition in HeLa Cells</p><p>(A) Influence diagram of G1/S regulatory network. Both CyclinE and CyclinA, as well as Emi1 (<xref rid="bib25" ref-type="bibr">Hsu et&#x000a0;al., 2002</xref>), are E2F target genes. The network is&#x000a0;characterized by multiple, mutual inhibitory network motifs. (1) APC/C<sup>Cdh1</sup> promotes the degradation of CyclinA, but Cdk2:CyclinA inhibits APC/C activation by Cdh1 (<xref rid="bib35" ref-type="bibr">Lukas et&#x000a0;al., 1999</xref>, <xref rid="bib72" ref-type="bibr">Zachariae et&#x000a0;al., 1998</xref>). (2) p27<sup>Kip1</sup> inhibits both Cdk2 kinase activities, but Cdk2:Cyclin complexes promote p27<sup>Kip1</sup> degradation directly and indirectly, thereby creating a coherent feed-forward loop. The direct effect is through phosphorylation of p27 at T187 that targets p27<sup>Kip1</sup> to the SCF-proteasome system (<xref rid="bib39" ref-type="bibr">Montagnoli et&#x000a0;al., 1999</xref>, <xref rid="bib57" ref-type="bibr">Sheaff et&#x000a0;al., 1997</xref>). The indirect effect is through upregulation of the SCF component, Skp2 by inhibiting its degradation machinery, APC/C<sup>Cdh1</sup>.</p><p>(B) The time courses for each of the cell-cycle reporters and Cdk2 activity was averaged across all&#x000a0;cells measured and aligned to S-phase entry (time 0).</p><p>(C) Numerical simulation of the G1/S control network with the deterministic version of the model (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Experimental Procedures</xref> for equations and parameter values).</p><p>(D) The steady-state dependence of p27<sup>Kip1</sup> level on CyclinE and Emi1 (the diagram is computed in the absence of CyclinA since its level is low during the G1/S transition) was calculated as a one-parameter bifurcation diagram with the deterministic version of the model. p27<sup>Kip1</sup> can settle at high and low levels (solid curves) at low and high CyclinE levels, respectively. The two states are separated by two different thresholds whose values are Emi1 dependent. The G1/S transition is characterized by the drop from the high to low level of p27<sup>Kip1</sup>.</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>G1/S Transition in CyclinE1,2-Depleted Cells</p><p>(A) Stochastic simulations of G1/S transition with 5% residual CyclinE synthesis (with 20-fold increase in mRNA degradation rate). Relative p27<sup>Kip1</sup> levels and free Cdk2:Cyclin complexes are shown.</p><p>(B) The CyclinA thresholds for p27<sup>Kip1</sup> inactivation and reactivation are plotted as a function of Emi1 levels with the deterministic model. The diagram is divided into three territories: low (green) and high (red) levels of p27<sup>Kip1</sup> and bistability (gray) where both of these states coexist. The trajectory of cell-cycle progression of CyclinE1/2-depleted cells is shown by a blue dashed curve.</p><p>(C and D) Time courses of p27<sup>Kip1</sup>-GFP level (C) and Cdk2 activity (D) in individual CyclinE1/2-depleted (color curves) and control siRNA-treated cells (gray curves). Both time courses are plotted from cell division, and S-phase entry is marked by a diamond on each curve. In (C), three independent experiments were conducted, and 8 (control siRNA) and 11 (CyclinE1/2 siRNA) cells are shown from one experiment. In (D), two independent experiments were conducted, and 10 (control siRNA) and 7 (CyclinE1/2 siRNA) cells are shown from one experiment.</p></caption><graphic xlink:href="gr3"/></fig><fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>G1/S Transition in CyclinA-Depleted Cells</p><p>(A) Stochastic simulations of the G1/S transition with 5% residual CyclinA synthesis (with 20-fold increase in mRNA degradation rate).</p><p>(B and C) Time courses of p27<sup>Kip1</sup>-GFP level (B) and Cdk2 activity (C) in individual CyclinA2-depleted (color curves) and control siRNA-treated cells (gray curves). Both time courses are plotted from cell division, and S-phase entry is marked by a diamond on each curve. In (B), three independent experiments were conducted, and ten (control siRNA) and nine (CyclinA2 siRNA) cells are shown from one experiment. In (C), two independent experiments were conducted, and ten (control siRNA) and ten (CyclinA2 siRNA) cells are shown from one experiment.</p></caption><graphic xlink:href="gr4"/></fig><fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Emi1 Is Required for an Irreversible G1/S Transition</p><p>(A) Stochastic simulation of Emi1 depletion. The initial state of the model corresponds to an S-phase cell (CyclinA increasing, CyclinE decreasing, and p27<sup>Kip1</sup> level is low, see <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C). At <italic>t&#x000a0;= 5h</italic>, the level and rate of synthesis of Emi1 were reduced by&#x000a0;90%, causing APC/C<sup>Cdh1</sup> reactivation, loss of CyclinA, and accumulation of p27<sup>Kip1</sup> and CyclinE. Later, the re-accumulation of CyclinE promotes the re-degradation of p27<sup>Kip1</sup>.</p><p>(B) DNA re-replication after Emi1 depletion. FACS plots of control (left) and Emi1-depleted (right) cells at 0, 24, and 48&#x000a0;hr after release from thymidine. Numbers shown on each graph are the percentage of cells with DNA &#x0003e; 4n.</p><p>(C) Experimental measurement of CyclinA2-GFP in Emi1-depleted cells. CyclinA2-GFP levels continue to increase at the beginning of the experiment, possibly since Emi1 is still functional. Later, CyclinA2-GFP levels decrease and remain low due to reactivation of APC/C<sup>Cdh1</sup> in the absence of Emi1. Two independent measurements were taken, and ten cells from one experiment are shown.</p><p>(D) Experimental measurement of p27<sup>Kip1</sup>-GFP in Emi1-depleted cells. p27<sup>Kip1</sup>-GFP is initially low and then shows a transient increase in some cells. Two independent measurements were taken, and eight cells from one experiment are shown.</p><p>(E) Experimental measurement of CyclinE1-GFP in Emi1-depleted cell. CyclinE1-GFP initially decreases and then continues to accumulate for the duration of the experiment. Two independent measurements were taken, and ten cells from one experiment are shown.</p><p>(F) Quantification of Cdk2 activity in Emi1-depleted cells. Two cells show a significant dip in Cdk2 activity. Other cells show a more moderate decrease. In all cases, individual curves represent individual cells. Three independent measurements were taken, and 11 cells from one experiment are shown.</p></caption><graphic xlink:href="gr5"/></fig><fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>G1 Progression in Cells with an Intact Restriction Point</p><p>(A) G1 control in cells with an intact restriction point including pRb control over E2F activity, as well E2F autoregulation.</p><p>(B) The steady-state levels of CyclinE (blue) and pRb (red) in the extended model are plotted against each other. Low hypo-phosphorylated pRb corresponds to high E2F activity. These balance curves of CyclinE and hypo-phosphorylated pRb create two qualitatively different steady states (high CyclinE, low pRb labeled &#x0201c;High&#x0201d; and low CyclinE, high pRb labeled &#x0201c;Low&#x0201d;) after cell division. The existence of two different cellular states (fates) is largely dependent on the inverse N-shaped characteristic of the pRb-balance curve (red) caused by the antagonism between Cdk2:CyclinE and CKI. In the absence of CKI, the red curve becomes a hyperbole, and the bistable regime is much reduced. The &#x0201c;dividing the way&#x0201d; behavior is illustrated by two trajectories (dotted arrows).</p><p>(C and D) Temporal evolution of free Cdk2:CyclinE (C) as well as E2F and hypo-phosphorylated pRb (D) in a cell approaching high and low Cdk2 activity states.</p></caption><graphic xlink:href="gr6"/></fig></floats-group></article>